资讯

Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first two implants carried out at University College London ...
BlueWind Medical has received a CE mark for its world’s-first wireless neurostimulation solution for overactive bladder (OAB). In a 36-patient trial carried out across four medical centres in ...
US-based medical device company Valencia Technologies has received a strategic investment of up to $35m and appointed James ...
Merck KGaA has joined forces with a unit of medtech firm B Braun – neuroloop – on a way to treat inflammatory diseases using neurostimulator devices. The German drugmaker will work with ...